Promegestone

This classification denotes a steroid compound with the molecular formula C22H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9XE0V2SQYX, chemically known as 17alpha-methyl-1,7-propionylestra-4,9-dien-3-one but generally known as promegestone, which bears US NIH Compound Identifier 36709. European Medicines Agency schedules Promegestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10086MIG. The term PROMEGESTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules promegestone in its Anatomical Therapeutic Chemical (ATC) Classification. PROMEGESTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule promegestone under HS 29372300 and SITC 54153. As of Q4 2014, PROMEGESTONE remains the US FDA Preferred Term for this commodity. Promegestone bears US NLM identifiers UMLS ID C0033401 and NCI Concept Code C66478. SMILES: O=C(C1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)CC2)CC1)C)C)CC.